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background:   We sought to validate the clinical utility of the J-CTO score in chronic total occlusion (CTO) percutaneous coronary 
intervention (PCI).
methods:  The records of 650 patients who underwent CTO PCI using the “hybrid” approach at six experienced CTO PCI centers were 
reviewed. Baseline characteristics and procedural outcomes were compared in patients with high (≥3) and low (<3) J-CTO scores. 
Multivariable logistic regression was performed to evaluate the score’s ability to predict technical success. The model goodness-of-fit was 
examined using receiver operator curves.
results:  Most patients (374 of 650, 58%) had a J-CTO score of ≥3. Patients with high J-CTO scores had higher frequency of dyslipidemia 
(97% vs. 92%, p=0.04), prior PCI (70% vs. 61%, p=0.015), and prior coronary artery bypass graft surgery (45% vs. 24%, p<0.001). The 
incidence of technical success, procedural success and major adverse cardiac events (MACE) were significantly lower in patients with 
J-CTO scores ≥3 (technical success 89.9% vs. 97.1%; procedural success 88.2% vs. 96.0%, MACE 2.1% vs. 1.1%, p<0.001). A high 
J-CTO score was associated with higher procedure times (123 [92-183] vs. 82 [55-129] minutes, p<0.001) and increased air-kerma 
radiation dose (4.4 [2.7-6.2] vs. 2.7 [1.7-5.1] Gray, p<0.001). The J-CTO score demonstrated good discrimination (c statistic=0.862)
Conclusion: J-CTO score is a very useful tool for predicting the technical and procedural success and efficiency of CTO PCI, supporting its 
expanded use.
 
